Physician profile
Duane Nelson
NPI 1841296498
$435.49
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $76.55 · 2021: $117 · 2022: $128.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $106.17 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $84.19 | 2019-2022 | |
| Shire North American Group INC | $57.98 | 2019 | |
| Allergan, INC. | $56.70 | 2020-2021 | |
| Rxsight INC | $32.31 | 2022 | |
| Leadiant Biosciences, INC. | $25.59 | 2020 | |
| Bausch & Lomb Americas INC. | $23.13 | 2022 | |
| Kala Pharmaceuticals, INC. | $19.47 | 2021 | |
| Carl Zeiss Meditec USA, INC. | $15.53 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.42 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Duane Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.